Cited by 505Opioid Use Disorder TreatmentNeuropeptides and Animal PhysiologyNeurotransmitter Receptor Influence on Behavior

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

The Neurobiology of Opioid Dependence: Implications for Treatment

Open access

Kosten, Thomas, George, Tony·2002·Science & Practice Perspectives

DOI 10.1151/spp021113PMC PMC2851054

Open this paper in CoChat — free account

Abstract

Opioid tolerance, dependence, and addiction are all manifestations of brain changes resulting from chronic opioid abuse. The opioid abuser's struggle for recovery is in great part a struggle to overcome the effects of these changes. Medications such as methadone, LAAM, buprenorphine, and naltrexone act on the same brain structures and processes as addictive opioids, but with protective or normalizing effects. Despite the effectiveness of medications, they must be used in conjunction with appropriate psychosocial treatments.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1151/spp021113

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Drug Addiction, Dysregulation of Reward, and Allostasis
Koob, G. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00195-0 · Cited by 2,953
The psychology and neurobiology of addiction: an incentive–sensitization view
Robinson, T. E., & Berridge, K. C. (2000) · Addiction · doi:10.1046/j.1360-0443.95.8s2.19.x · Cited by 1,507
Acute effects of cocaine on human brain activity and emotion
Breiter, H. C., Gollub, R. L., Weisskoff, R. M., Kennedy, D. N., Makris, N., Berke, J. D., Goodman, J. M., Kantor, H. L., Gastfriend, D. R., Riorden, J. P., et al. (1997) · Neuron · doi:10.1016/s0896-6273(00)80374-8 · Cited by 1,270
Reduced Prefrontal Gray Matter Volume and Reduced Autonomic Activity in Antisocial Personality Disorder
Raine, A., Lencz, T., Bihrle, S., LaCasse, L., & Colletti, P. M. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.2.119 · Cited by 1,053
Stress-induced relapse to heroin and cocaine seeking in rats: a review
Shaham, Y., Erb, S. M., & Stewart, J. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00024-2 · Cited by 704
Drug dependence: stress and dysregulation of brain reward pathways
Kreek, M. J., & Koob, G. F. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00064-7 · Cited by 696
Effective Medical Treatment of Opiate Addiction
Addiction, N. C. D. P. O. E. M. T. O. O. (1998) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.280.22.1936 · Cited by 577
The tonic/phasic model of dopamine system regulation and its implications for understanding alcohol and psychostimulant craving
Grace, A. A. (2000) · Addiction · doi:10.1046/j.1360-0443.95.8s2.1.x · Cited by 433
Buprenorphine vs Methadone Maintenance Treatment for Concurrent Opioid Dependence and Cocaine Abuse
Schottenfeld, R. S. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830200041006 · Cited by 300
Buprenorphine versus Methadone Maintenance for Opioid Dependence
KOSTEN, T. R., SCHOTTENFELD, R., ZIEDONIS, D., & FALCIONI, J. (1993) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199306000-00004 · Cited by 267
Self-citation

Flagged first, then by citations

Show all 24 references

Sorted by citations

Prevention and Treatment of Opioid Misuse and Addiction: A Review
Volkow, N. D., Jones, E. B., Einstein, E. B., & Wargo, E. M. (2019) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2018.3126 · Cited by 596
Targeting voltage-gated calcium channels in neurological and psychiatric diseases
Zamponi, G. W. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.5 · Cited by 374
Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development
Koob, G. F. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000083 · Cited by 337
Opioid Analgesia and Opioid-Induced Adverse Effects: A Review
Paul, A. K., Smith, C. M., Rahmatullah, M., Nissapatorn, V., Wilairatana, P., Spetea, M., Gueven, N., & Dietis, N. (2021) · Pharmaceuticals · doi:10.3390/ph14111091 · Cited by 332
Adverse events associated with medium- and long-term use of opioids for chronic non-cancer pain: an overview of Cochrane Reviews
Els, C., Jackson, T., Kunyk, D., Lappi, V. G., Sonnenberg, B., Hagtvedt, R., Sharma, S., Kolahdooz, F., & Straube, S. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012509.pub2 · Cited by 304
The United States opioid epidemic
Lyden, J. R., & Binswanger, I. A. (2019) · Seminars in Perinatology · doi:10.1053/j.semperi.2019.01.001 · Cited by 262
Nonmedical Prescription Opioid Use in Childhood and Early Adolescence Predicts Transitions to Heroin Use in Young Adulthood: A National Study
Cerdá, M., Santaella-Tenorio, J., Marshall, B. D. L., Kim, J. H., & Martins, S. S. (2015) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2015.04.071 · Cited by 248
Review article: Effective management of opioid withdrawal symptoms: A gateway to opioid dependence treatment
Kosten, T. R., & Baxter, L. E. (2019) · American Journal on Addictions · doi:10.1111/ajad.12862 · Cited by 236
Self-citation
Opioid withdrawal symptoms, a consequence of chronic opioid use and opioid use disorder: Current understanding and approaches to management
Pergolizzi, J. V., Raffa, R. B., & Rosenblatt, M. (2020) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.13114 · Cited by 234
Medication-Assisted Treatment of Adolescents With Opioid Use Disorders
Ryan, S. A., Gonzalez, P. K., Patrick, S. W., Quigley, J. M., Siqueira, L. M., & Walker, L. R. (2016) · PEDIATRICS · doi:10.1542/peds.2016-1893 · Cited by 224
Adverse events associated with medium- and long-term use of opioids for chronic non-cancer pain: an overview of Cochrane Reviews
Els, C., Kunyk, D., Lappi, V. G., Sonnenberg, B., Hagtvedt, R., Sharma, S., Kolahdooz, F., & Straube, S. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012509 · Cited by 192
Opioid agonist treatment and fatal overdose risk in a state‐wide US population receiving opioid use disorder services
Krawczyk, N., Mojtabai, R., Stuart, E. A., Fingerhood, M., Agus, D., Lyons, B. C., Weiner, J. P., & Saloner, B. (2020) · Addiction · doi:10.1111/add.14991 · Cited by 177
Efficacy of lofexidine for mitigating opioid withdrawal symptoms: results from two randomized, placebo-controlled trials
Alam, D., Tirado, C. F., Pirner, M., & Clinch, T. (2020) · Journal of Drug Assessment · doi:10.1080/21556660.2019.1704416 · Cited by 171
Opioid Receptor-Mediated Regulation of Neurotransmission in the Brain
Reeves, K. C., Shah, N., Muñoz, B., & Atwood, B. K. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.919773 · Cited by 156
New directions in the treatment of opioid withdrawal
Srivastava, A. B., Mariani, J. J., & LEVIN, F. R. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30852-7 · Cited by 148
Evidence-Based Treatment of Opioid-Dependent Patients
van den Brink, W., & Haasen, C. (2006) · The Canadian Journal of Psychiatry · doi:10.1177/070674370605101003 · Cited by 147
Craving in Opioid Use Disorder: From Neurobiology to Clinical Practice
Kakko, J., Alho, H., Baldacchino, A., Molina, R., Nava, F. A., & Shaya, G. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00592 · Cited by 140
Inhibition of FAAH and activation of PPAR: New approaches to the treatment of cognitive dysfunction and drug addiction
Panlilio, L. V., Justinová, Z., & Goldberg, S. R. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.003 · Cited by 106
The opioid system in depression
Jelen, L. A., Stone, J. M., Young, A. H., & Mehta, M. A. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104800 · Cited by 108
Treating Diabetic Neuropathy: Present Strategies and Emerging Solutions
Javed, S., Alam, U., & Malik, R. A. (2015) · The Review of Diabetic Studies · doi:10.1900/rds.2015.12.63 · Cited by 92
Medical cannabis for the reduction of opioid dosage in the treatment of non-cancer chronic pain: a systematic review
Okusanya, B. O., Asaolu, I. O., Ehiri, J. E., Kimaru, L. J., Okechukwu, A., & Rosales, C. (2020) · Systematic Reviews · doi:10.1186/s13643-020-01425-3 · Cited by 91
Dopamine D3R antagonist VK4-116 attenuates oxycodone self-administration and reinstatement without compromising its antinociceptive effects
You, Z., Bi, G., Galaj, E., Kumar, V., Cao, J., Gadiano, A. J., Rais, R., Slusher, B. S., Gardner, E. L., Xi, Z., et al. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0284-5 · Cited by 82
Pharmacological treatments for heroin and cocaine addiction
van den Brink, W., & van Ree, J. M. (2003) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2003.08.008 · Cited by 80
Comparative metabolism of tramadol and tapentadol: a toxicological perspective
Barbosa, J., Faria, J., Queirós, O., Moreira, R. F., Carvalho, F. D., & Dinis‐Oliveira, R. J. (2016) · Drug Metabolism Reviews · doi:10.1080/03602532.2016.1229788 · Cited by 78
Treating osteoarthritis pain: mechanisms of action of acetaminophen, nonsteroidal anti-inflammatory drugs, opioids, and nerve growth factor antibodies
D’Arcy, Y. M., Mantyh, P. W., Yaksh, T. L., Donevan, S. D., Hall, J. A., Sadrarhami, M. M., & Viktrup, L. (2021) · Postgraduate Medicine · doi:10.1080/00325481.2021.1949199 · Cited by 72
High-dose opioids for chronic non-cancer pain: an overview of Cochrane Reviews
Els, C., Jackson, T., Hagtvedt, R., Kunyk, D., Sonnenberg, B., Lappi, V. G., & Straube, S. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012299.pub2 · Cited by 75
Designing Safer Analgesics via μ-Opioid Receptor Pathways
Chan, H. C. S., McCarthy, D. R., Li, J., Palczewski, K., & Yuan, S. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.08.004 · Cited by 76
Discovery of a Novel Site of Opioid Action at the Innate Immune Pattern-Recognition Receptor TLR4 and its Role in Addiction
Jacobsen, J. H. W., Watkins, L. R., & Hutchinson, M. R. (2014) · International review of neurobiology · doi:10.1016/b978-0-12-801284-0.00006-3 · Cited by 72
Progress in agonist therapy for substance use disorders: Lessons learned from methadone and buprenorphine
Jordan, C. J., Cao, J., Newman, A. H., & Xi, Z. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.04.015 · Cited by 70
Naloxone-precipitated morphine withdrawal behavior and brain IL-1β expression: Comparison of different mouse strains
Liu, L., Coller, J. K., Watkins, L. R., Somogyi, A. A., & Hutchinson, M. R. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.03.016 · Cited by 66
The “addicted” spine
Spiga, S., Mulas, G., Piras, F., & Diana, M. (2014) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2014.00110 · Cited by 63
The effect of sertraline and environmental context on treating depression and illicit substance use among methadone maintained opiate dependent patients: a controlled clinical trial
Carpenter, K. M., Brooks, A. C., Vosburg, S. K., & Nunes, E. V. (2004) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2003.11.015 · Cited by 64
Unlocking opioid neuropeptide dynamics with genetically encoded biosensors
Dong, C., Gowrishankar, R., Jin, Y., He, X. J., Gupta, A., Wang, H., Sayar, N., Flores, R. J., Mahe, K., Tjahjono, N., et al. (2024) · Nature Neuroscience · doi:10.1038/s41593-024-01697-1 · Cited by 60
A Critical Review of the Social and Behavioral Contributions to the Overdose Epidemic
Cerdá, M., Krawczyk, N., Hamilton, L., Rudolph, K. E., Friedman, S. R., & Keyes, K. M. (2020) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-090419-102727 · Cited by 61
Mechanisms, Diagnosis, Prevention and Management of Perioperative Opioid-Induced Hyperalgesia
Wilson, S. H., Hellman, K. M., James, D. L., Adler, A. C., & Chandrakantan, A. (2021) · Pain Management · doi:10.2217/pmt-2020-0105 · Cited by 56
Are Adolescent Substance Users Less Satisfied with Life as Young Adults and if so, Why?
Bogart, L. M., Collins, R. L., Ellickson, P. L., & Klein, D. J. (2006) · Social Indicators Research · doi:10.1007/s11205-006-0019-6 · Cited by 59
Molecular Adaptations in the Rat Dorsal Striatum and Hippocampus Following Abstinence-Induced Incubation of Drug Seeking After Escalated Oxycodone Self-Administration
Blackwood, C. A., Hoerle, R., Leary, M., Schroeder, J. R., Job, M. O., McCoy, M. T., Ladenheim, B., Jayanthi, S., & Cadet, J. L. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1318-z · Cited by 56
Safety and Efficacy of Lofexidine for Medically Managed Opioid Withdrawal: A Randomized Controlled Clinical Trial
Fishman, M. J., Tirado, C. F., Alam, D., Gullo, K. L., Clinch, T., & Gorodetzky, C. W. (2018) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000474 · Cited by 56
Associations between classic psychedelics and opioid use disorder in a nationally-representative U.S. adult sample
Jones, G. M., Ricard, J., Lipson, J., & Nock, M. (2022) · Scientific Reports · doi:10.1038/s41598-022-08085-4 · Cited by 52
OPRM1 A118G Polymorphisms and Its Role in Opioid Addiction: Implication on Severity and Treatment Approaches
Taqi, M. M., Faisal, M., & Zaman, H. (2019) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s198654 · Cited by 55
Targeting TRPV1 as an Alternative Approach to Narcotic Analgesics to Treat Chronic Pain Conditions
Premkumar, L. S. (2010) · The AAPS Journal · doi:10.1208/s12248-010-9196-y · Cited by 51
Iatrogenic Opioid Withdrawal in Critically Ill Patients: A Review of Assessment Tools and Management
Chiu, A. W., Contreras, S., Mehta, S., Korman, J., Perreault, M. M., Williamson, D. R., & Burry, L. D. (2017) · Annals of Pharmacotherapy · doi:10.1177/1060028017724538 · Cited by 48
Association of childhood abuse and prescription opioid use in early adulthood
Austin, A. E., Shanahan, M. E., & Zvara, B. J. (2017) · Addictive Behaviors · doi:10.1016/j.addbeh.2017.08.033 · Cited by 48
Fecal microbiota transplantation and antibiotic treatment attenuate naloxone-precipitated opioid withdrawal in morphine-dependent mice
Thomaz, A. C., Iyer, V., Woodward, T. J., & Hohmann, A. G. (2021) · Experimental Neurology · doi:10.1016/j.expneurol.2021.113787 · Cited by 49
Effective analgesic doses of tramadol or tapentadol induce brain, lung and heart toxicity in Wistar rats
Faria, J., Barbosa, J., Leal, S. M., Afonso, L. P., Lobo, J., Moreira, R. F., Queirós, O., Carvalho, F. D., & Dinis‐Oliveira, R. J. (2017) · Toxicology · doi:10.1016/j.tox.2017.05.003 · Cited by 46
Understanding the neurobiological effects of drug abuse: Lessons from zebrafish models
Müller, T. E., Fontana, B. D., Bertoncello, K. T., Franscescon, F., Mezzomo, N. J., Canzian, J., Stefanello, F. V., Parker, M. O., Gerlai, R. T., & Rosemberg, D. B. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.109873 · Cited by 51
Mechanisms of SSRI Therapy and Discontinuation
Sharp, T., & Collins, H. (2023) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2023_452 · Cited by 55
Associations between neighborhood‐level factors and opioid‐related mortality: A multi‐level analysis using death certificate data
Flores, M. W., Cook, B. L., Mullin, B. O., Halperin‐Goldstein, G., Nathan, A., Tenso, K., & Schuman‐Olivier, Z. (2020) · Addiction · doi:10.1111/add.15009 · Cited by 46
Improved Quality of Life, Clinical, and Psychosocial Outcomes Among Heroin-dependent Patients on Ambulatory Buprenorphine Maintenance
Ponizovsky, A. M., Margolis, A., Heled, L., Rosca, P., Radomislensky, I., & Grinshpoon, A. (2009) · Substance Use & Misuse · doi:10.3109/10826080902873010 · Cited by 45
The use of auricular acupuncture in opioid use disorder: A systematic literature review
Baker, T. E., & Chang, G. (2016) · American Journal on Addictions · doi:10.1111/ajad.12453 · Cited by 44
Iatrogenic Opioid Withdrawal Syndrome in Critically Ill Patients: a Retrospective Cohort Study
Hyun, D., Huh, J. W., Hong, S., Koh, Y., & Lim, C. (2020) · Journal of Korean Medical Science · doi:10.3346/jkms.2020.35.e106 · Cited by 40
Role of microRNAs in the pathophysiology of addiction
Gowen, A. M., Odegaard, K. E., Hernandez, J. B., Chand, S., Koul, S., Pendyala, G., & Yelamanchili, S. V. (2020) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1637 · Cited by 40
Fentanyl self-administration impacts brain immune responses in male Sprague-Dawley rats
Ezeomah, C., Cunningham, K. A., Stutz, S. J., Fox, R. G., Bukreyeva, N., Dineley, K. T., Paessler, S., & Cisneros, I. E. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.03.003 · Cited by 39
Nutritional implications of opioid use disorder: A guide for drug treatment providers
Chavez, M. N., & Rigg, K. K. (2020) · Psychology of Addictive Behaviors · doi:10.1037/adb0000575 · Cited by 38
Acute administration of tramadol and tapentadol at effective analgesic and maximum tolerated doses causes hepato- and nephrotoxic effects in Wistar rats
Barbosa, J., Faria, J., Leal, S. M., Afonso, L. P., Lobo, J., Queirós, O., Moreira, R. F., Carvalho, F. D., & Dinis‐Oliveira, R. J. (2017) · Toxicology · doi:10.1016/j.tox.2017.07.001 · Cited by 34
Long-Acting Injectable naltrexone for the Management of patients with Opioid Dependence
Kjome, K. L., & Moeller, F. G. (2011) · Substance Abuse Research and Treatment · doi:10.4137/sart.s5452 · Cited by 34
Use of epidural clonidine for the management of analgesia in the opioid addicted parturient on buprenorphine maintenance therapy: an observational study
Hoyt, M. R., Shah, U. R., Cooley, J., & Temple, M. (2018) · International Journal of Obstetric Anesthesia · doi:10.1016/j.ijoa.2018.01.001 · Cited by 33
Deep Brain Stimulation in Drug Addiction Treatment: Research Progress and Perspective
Chang, R., Peng, J., Chen, Y., Liao, H., Zhao, S., Zou, J., & Tan, S. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.858638 · Cited by 36
Treatment of painful diabetic peripheral neuropathy
Rosenberg, C. J., & Watson, J. C. (2015) · Prosthetics and Orthotics International · doi:10.1177/0309364614542266 · Cited by 33
Effect of Long-Term Opioid Use on Dementia Risk in Patients with Chronic Pain
Sun, M., Chen, W., Wu, S., & Zhang, J. (2022) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2023.06.035 · Cited by 33
Medications for Opioid Use Disorder, Opioid Withdrawal, and Opioid Overdose
Harris, M. T. H., Weinstein, Z., & Walley, A. Y. (2026) · JAMA · doi:10.1001/jama.2025.26348 · Cited by 31
Determination of Peptide Profile Consistency and Safety of Collagen Hydrolysates as Quality Attributes
López‐Morales, C. A., Vázquez‐Leyva, S., Vallejo‐Castillo, L., Carballo‐Uicab, G., Muñoz‐García, L., Pucheta, J. E. H., Zepeda, L. G., Velasco-Velázquez, M. A., Pavón, L., Pérez‐Tapia, S. M., et al. (2019) · Journal of Food Science · doi:10.1111/1750-3841.14466 · Cited by 31
Psychopharmacology of Addiction
Uğurlu, T. T., Şengül, C. B., & Şengül, C. (2011) · Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry · doi:10.5455/cap.20120403 · Cited by 30
Tafalgin is a Russian innovative tetrapeptide pharmaceutical for subcutaneous injection: review of the results of phase I and II clinical trials
Kosorukov, V. S., Abuzarova, G. R., Ревовна, З. Е., Gamzeleva, O. Y., & Yatsenko, K. A. (2022) · Head and neck tumors (HNT) · doi:10.17650/2222-1468-2022-12-2-89-107 · Cited by 30
Sexually dimorphic neuroimmune response to chronic opioid treatment and withdrawal
Kumar, M., Rainville, J. R., Williams, K., Lile, J. A., Hodes, G. E., Vassoler, F. M., & Turner, J. R. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108469 · Cited by 27
Oxytocin and Addiction: Potential Glutamatergic Mechanisms
Sundar, M., Patel, D., Young, Z., & Leong, K.-C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052405 · Cited by 31
Early Life Stress and Risks for Opioid Misuse: Review of Data Supporting Neurobiological Underpinnings
Oswald, L. M., Dunn, K. E., Seminowicz, D. A., & Storr, C. L. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11040315 · Cited by 29
The Effect of Propranolol and Midazolam on the Reconsolidation of a Morphine Place Preference in Chronically Treated Rats
Robinson, M. J., Armson, M. J., & Franklin, K. B. J. (2011) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2011.00042 · Cited by 27
Behavioral effects of fatty acid amide hydrolase inhibition on morphine withdrawal symptoms
Shahidi, ‬., & Hasanein, P. (2011) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2011.06.019 · Cited by 30
Pharmacokinetic and pharmacodynamic considerations in developing a response to the opioid epidemic
Balyan, R., Hahn, D., Huang, H. D., & Chidambaran, V. (2020) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2020.1721458 · Cited by 29
Day-to-day opioid withdrawal symptoms, psychological distress, and opioid craving in patients with chronic pain prescribed opioid therapy
Bruneau, A., Frimerman, L., Verner, M., Sirois, A., Fournier, C., Scott, K., Pérez, J., Shir, Y., & Martel, M. O. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.108787 · Cited by 29
The gabapentinoid drugs and their abuse potential
Goins, A. E., Patel, K., & Alles, S. R. A. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107926 · Cited by 27
High-dose naloxone formulations are not as essential as we thought
Lemen, P. M., Garrett, D. P., Thompson, E., Aho, M., Vasquez, C., & Park, J. N. (2024) · Harm Reduction Journal · doi:10.1186/s12954-024-00994-z · Cited by 30
Dying on Hospice in the Midst of an Opioid Crisis: What Should We Do Now?
Gabbard, J., Jordan, A. E., Mitchell, J., Corbett, M., White, P., & Childers, J. W. (2018) · American Journal of Hospice and Palliative Medicine® · doi:10.1177/1049909118806664 · Cited by 27
Central antagonism of orexin type-1 receptors attenuates the development of morphine dependence in rat locus coeruleus neurons
Fakhari, M., Azizi, H., & Semnanian, S. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.08.054 · Cited by 26
Opioid use during pregnancy can impair maternal behavior and the Maternal Brain Network: A literature review
Wallin, C. M., Bowen, S. E., & Brummelte, S. (2021) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2021.106976 · Cited by 27
Opioids-induced inhibition of HERG ion channels and sudden cardiac death, a systematic review of current literature
Sherbini, A. E., Liblik, K., Lee, J., Baranchuk, A. M., Zhang, S., & El-Diasty, M. M. (2023) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2023.03.006 · Cited by 28
Opioid Detoxification in Pregnancy: Systematic Review and Meta-Analysis of Perinatal Outcomes
Wang, M. J., Kuper, S. G., Sims, B., Paddock, C. S., Dantzler, J., Muir, S., & Harper, L. M. (2018) · American Journal of Perinatology · doi:10.1055/s-0038-1670680 · Cited by 25
Opioid system and related ligands: from the past to future perspectives
Rullo, L., Morosini, C., Lacorte, A., Cristani, M., Coluzzi, F., Candeletti, S., & Romualdi, P. (2024) · Journal of Anesthesia Analgesia and Critical Care · doi:10.1186/s44158-024-00201-2 · Cited by 26
Narrative Review on Postoperative Pain Management Following Spine Surgery
Yu, C., Madsen, M. W., Akande, O., Oh, M. Y., Mattie, R., & Lee, D. W. (2025) · Neurospine · doi:10.14245/ns.2550410.205 · Cited by 24
Naltrexone Implant for Opioid Use Disorder
Edinoff, A. N., Nix, C. A., Orellana, C. V., StPierre, S., Crane, E. A., Bulloch, B. T., Cornett, E. M., Kozinn, R. L., Kaye, A. M., Murnane, K. S., et al. (2021) · Neurology International · doi:10.3390/neurolint14010004 · Cited by 25
Substance use, microbiome and psychiatric disorders
Chivero, E. T., Sil, S., Kumar, M., & Buch, S. J. (2022) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2022.173432 · Cited by 26
Effect of Preoperative Opioid Usage on Pain After Total Shoulder Arthroplasty
Curtis, W., Rounds, A. D., Stone, M., Vangsness, C. T., Weber, A. E., Hatch, G. F. R., & Omid, R. (2018) · Journal of the American Academy of Orthopaedic Surgeons · doi:10.5435/jaaos-d-18-00112 · Cited by 24
Assessing Neonates for Neonatal Abstinence
D'Apolito, K. (2014) · The Journal of Perinatal & Neonatal Nursing · doi:10.1097/jpn.0000000000000056 · Cited by 23
Novel treatments for chronic pain: moving beyond opioids
O’Brien, J. B., & Roman, D. L. (2021) · Translational research · doi:10.1016/j.trsl.2021.03.008 · Cited by 22
Naloxone precipitated withdrawal increases dopamine release in the dorsal striatum of opioid dependent men
Kojori, E. S., Wang, G., & Volkow, N. D. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01548-8 · Cited by 23
The Role of Physical Exercise in Opioid Substitution Therapy: Mechanisms of Sequential Effects
Psarianos, A., Chryssanthopοulos, C., Paparrigopoulos, T. J., & Philippou, Α. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054763 · Cited by 25
Glymphatic-System Function Is Associated with Addiction and Relapse in Heroin Dependents Undergoing Methadone Maintenance Treatment
Wang, L., Qin, Y., Li, X., Li, X., Liu, Y., Li, W., & Wang, Y. (2023) · Brain Sciences · doi:10.3390/brainsci13091292 · Cited by 21
Antinociceptive effects of flower extracts and the active fraction from Styrax japonicus
He, L., Zhou, Y., Wan, G., Wang, W., Zhang, N., & Yao, L. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114779 · Cited by 21
Iatrogenic opioid withdrawal syndromes in adults in intensive care units: a narrative review
Lamey, P. S., Landis, D. M., & NUGENT, K. M. (2022) · Journal of Thoracic Disease · doi:10.21037/jtd-22-157 · Cited by 21
A phenomenological investigation into the lived experience of ibogaine and its potential to treat opioid use disorders
Camlin, T. J., Eulert, D., Horvath, A. T., Bucky, S. F., Barsuglia, J. P., & Polanco, M. (2018) · Journal of Psychedelic Studies · doi:10.1556/2054.2018.004 · Cited by 21
Zerumbone-Induced Analgesia Modulated via Potassium Channels and Opioid Receptors in Chronic Constriction Injury-Induced Neuropathic Pain
Gopalsamy, B., Chia, J. S. M., Farouk, A. A. O., Sulaiman, M. R., & Perimal, E. K. (2020) · Molecules · doi:10.3390/molecules25173880 · Cited by 21
Well-being, psychosocial factors, and side-effects among heroin-dependent inpatients after detoxification using buprenorphine versus clonidine
Ponizovsky, A. M., Grinshpoon, A., Margolis, A., Cohen, R., & Rosca, P. (2006) · Addictive Behaviors · doi:10.1016/j.addbeh.2006.01.014 · Cited by 21
Eluxadoline Demonstrates a Lack of Abuse Potential in Phase 2 and 3 Studies of Patients With Irritable Bowel Syndrome With Diarrhea
Fant, R., Henningfield, J., Cash, B., Dove, L. S., & Covington, P. (2017) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2017.01.026 · Cited by 21
High-dose opioids for chronic non-cancer pain: an overview of Cochrane Reviews
Els, C., Jackson, T., Hagtvedt, R., Kunyk, D., Sonnenberg, B., Lappi, V. G., & Straube, S. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012299.pub3 · Cited by 22
Management of opioid dependence
van den Brink, W., Goppel, M., & van Ree, J. M. (2003) · Current Opinion in Psychiatry · doi:10.1097/00001504-200305000-00005 · Cited by 20
High-dose opioids for chronic non-cancer pain: an overview of Cochrane reviews
Els, C., Hagtvedt, R., Kunyk, D., Sonnenberg, B., Lappi, V. G., & Straube, S. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012299 · Cited by 20
The neural circuits and signalling pathways of opioid use disorder
Mathis, V., Ehrlich, A. T., & Darcq, E. (2025) · Nature reviews. Neuroscience · doi:10.1038/s41583-025-00982-7 · Cited by 23
Opioid Use After ICU Admission Among Elderly Chronic Opioid Users in Ontario: A Population-Based Cohort Study
Wang, H. T., Hill, A. D., Gomes, T., Wijeysundera, D. N., Pinto, R. L., Scales, D. C., Fowler, R., & Wunsch, H. (2018) · Critical Care Medicine · doi:10.1097/ccm.0000000000003401 · Cited by 19
Targeting Opioid Receptors in Addiction and Drug Withdrawal: Where Are We Going?
Tabanelli, R., Brogi, S., & Calderone, V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310888 · Cited by 20

Authors: Kosten, T., & George, T.
Affiliations: Yale University (US)
Corresponding author: Kosten, Thomas
ORCID: Kosten, Thomas
George, Tony
Venue: Science & Practice Perspectives
Publisher: NIDA/RTI International
Published: 2002-07
Volume: 1
Issue: 1
Pages: 13-20
ISSN: 1930-4307 (ISSN-L)
1930-4315
DOI: 10.1151/spp021113
PMC: PMC2851054
OpenAlex: W1997980357
Cited by: 505
References: 24
Citations by year: 2026: 34 · 2025: 46 · 2024: 38 · 2023: 53 · 2022: 56 · 2021: 55 · 2020: 46 · 2019: 33 · 2018: 32 · 2017: 27 · 2016: 22 · 2015: 18 · 2014: 8 · 2013: 5 · 2012: 2
FWCI: 1.75
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Science & Practice Perspectives (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Institute on Drug Abuse (R01-DA-1-4039, P50 DA12762, K05‐DA00454, R01-DA-1-3672, K12 DA00167)
Topics: Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Keywords: opioid use disorder, opioid tolerance, neurobiology of addiction, methadone maintenance treatment, LAAM, buprenorphine, naltrexone, opioid antagonists, psychosocial interventions, addiction treatment
MeSH terms: Analgesics, Opioid, Brain, Humans, Models, Neurological, Narcotic Antagonists, Opioid-Related Disorders, Receptors, Opioid, Behavior, Addictive

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Neurobiology of Opioid Dependence: Implications for Treatment

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks